AMIH - Technical Pull Back
Diupdate
American International Holdings has been on a very nice rally but we are due for a pull back and slightly overbought. We have pinning tops on 4hr and daily, with rejection of the 200ema on the 4hr. Not financial advice, DYOR.
Recent News
AMIH Majority Owned Subsidiary, EPIQ Scripts, Obtains Controlled Substance Registration from the U.S. Department of Justice & Drug Enforcement Administration (DEA)
American International Holdings Corp.
December 1, 2022
Dallas, Texas, Dec. 01, 2022 (GLOBE NEWSWIRE) -- American International Holdings Corp. (OTCQB: AMIH), (“AMIH” or the “Company”), a diversified holding company that develops, acquires, and operates technology-based health and wellness companies, is pleased to announce that its majority owned subsidiary, EPIQ Scripts, LLC (“EPIQ Scripts”), has been granted a controlled substance registration (CSR) from the U.S. Department of Justice & Drug Enforcement Administration (“DEA License”).
In addition to obtaining its DEA License, EPIQ Scripts has submitted applications with various national accreditation associations including the Utilization Review Accreditation Commission (URAC) for both mail order and specialty pharmacy accreditations, LegitScript for its online healthcare merchant certification, the Accreditation Commission for Health Care (ACHC) and Pharmacy Compounding Accreditation Board (PCAB) for non-sterile pharmacy compounding and has become a member of the National Council for Prescription Drug Programs (NCPDP) and the American Telemedicine Association. We can provide no assurance that such licenses and accreditations applied for will be approved on a timely basis, if at all.
“Our goal is to eventually position EPIQ Scripts to compete with TruePill - the online pharmacy most recently valued at $1.6 billion, that provides fulfillment services to popular telemedicine companies such as Hims and Hers and GoodRx - and other online digital pharmacies, as we seek to rapidly rollout our solutions in the sizeable telemedicine markets,” commented Sultan Haroon, Manager and Director of Operations of EPIQ Scripts, who continued, “Obtaining the DEA License and with our pharmacy now licensed to operate and fulfill prescriptions in nearly 30 U.S. States, we believe EPIQ Scripts is in a better position to attract and support direct-to-consumer telemedicine companies seeking to reach customers on a national level.”
Recent News
AMIH Majority Owned Subsidiary, EPIQ Scripts, Obtains Controlled Substance Registration from the U.S. Department of Justice & Drug Enforcement Administration (DEA)
American International Holdings Corp.
December 1, 2022
Dallas, Texas, Dec. 01, 2022 (GLOBE NEWSWIRE) -- American International Holdings Corp. (OTCQB: AMIH), (“AMIH” or the “Company”), a diversified holding company that develops, acquires, and operates technology-based health and wellness companies, is pleased to announce that its majority owned subsidiary, EPIQ Scripts, LLC (“EPIQ Scripts”), has been granted a controlled substance registration (CSR) from the U.S. Department of Justice & Drug Enforcement Administration (“DEA License”).
In addition to obtaining its DEA License, EPIQ Scripts has submitted applications with various national accreditation associations including the Utilization Review Accreditation Commission (URAC) for both mail order and specialty pharmacy accreditations, LegitScript for its online healthcare merchant certification, the Accreditation Commission for Health Care (ACHC) and Pharmacy Compounding Accreditation Board (PCAB) for non-sterile pharmacy compounding and has become a member of the National Council for Prescription Drug Programs (NCPDP) and the American Telemedicine Association. We can provide no assurance that such licenses and accreditations applied for will be approved on a timely basis, if at all.
“Our goal is to eventually position EPIQ Scripts to compete with TruePill - the online pharmacy most recently valued at $1.6 billion, that provides fulfillment services to popular telemedicine companies such as Hims and Hers and GoodRx - and other online digital pharmacies, as we seek to rapidly rollout our solutions in the sizeable telemedicine markets,” commented Sultan Haroon, Manager and Director of Operations of EPIQ Scripts, who continued, “Obtaining the DEA License and with our pharmacy now licensed to operate and fulfill prescriptions in nearly 30 U.S. States, we believe EPIQ Scripts is in a better position to attract and support direct-to-consumer telemedicine companies seeking to reach customers on a national level.”
Catatan
Just got filled for a long at weekly VWAP $.0087
Publikasi terkait
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.